Leukemic cutaneous T-cell lymphoma (L-CTCL) is a rare type of skin cancer that presents varied clinical features and symptoms. In a recently in pre-print published study by the University of Veterinary Medicine Vienna and the Medical Universities of Vienna and Graz, the researchers managed to integrate the genomic data from affected patients with pharmacologic studies. This innovative research approach has led to the identification of STAT3/5 and PAK kinase as potential new therapeutic targets.


Quick Links